Results 161 to 170 of about 8,172 (215)

Severe Viper Envenomation: A Case Report From Portugal. [PDF]

open access: yesCureus
Vitó Madureira B   +3 more
europepmc   +1 more source

Assessing territorial disparities in snakebite surveillance data in Brazil: Implications for public health. [PDF]

open access: yesPLoS Negl Trop Dis
Silva-Neto AV   +11 more
europepmc   +1 more source

The SnaFab versus the Razi antivenom for treatment of snakebite envenomation: A randomized, double-blind (investigator and victims), active controlled, non-inferiority clinical trial. [PDF]

open access: yesPLOS Glob Public Health
Mousavi SR   +13 more
europepmc   +1 more source

Retrospective Comparison of Empiric Antivenom vs. Expectant Treatment for Eastern Coral Snakebites. [PDF]

open access: yesWest J Emerg Med
Simmons R   +11 more
europepmc   +1 more source

A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa

open access: yesToxicon, 2003
Currently there is a crisis in the supply of antivenom for treatment of snake bite in sub-Saharan Africa. Commercial pressures have resulted in the reduction or even cessation of production of antivenom by European manufacturers while continued ...
G D Laing   +2 more
exaly   +2 more sources

Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa

open access: yesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
A polyspecific Pan-African antivenom has been produced from the plasma of horses immunized with a mixture of the venoms of Echis ocellatus, Bitis arietans and Naja nigricollis, the three most medically important snakes in sub-Saharan Africa.
G D Laing   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Availability of adder antivenom

Veterinary Record, 2014
WE read with interest the letter on the availability of adder antivenom by Alan Sim ( VR , June 7, 2014, vol 174, p 586) and share his concerns. Supply of adder antivenom for the treatment of animals is always an issue but has recently become more acute with the cessation of production of European Adder Antivenom …
Nicola, Bates, Nick, Edwards
openaire   +4 more sources

Antivenom Therapy in the Americas

Drugs, 1999
Envenomations are an important cause of injury in the Americas. While supportive care alone may result in an acceptable outcome, antivenom offers a specific therapy that can significantly reduce the injury and symptoms of the envenomation. Antivenoms are hyperimmune sera collected from animals immunised with venom. The antibodies contained in the serum
K, Heard, G F, O'Malley, R C, Dart
openaire   +2 more sources

Snake antivenom trial

Veterinary Record, 2014
WE would like to invite veterinary practitioners to take part in a clinical trial of Europe's first dedicated veterinary snake antivenom, ViperaVet. This is directed against the venom of four medically important Vipera species found throughout western Europe, including the adder ( Vipera berus) , Britain's only native venomous snake. Between September
Fiona, Bolton   +2 more
openaire   +2 more sources

Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming [PDF]

open access: yesToxins, 2017
Antivenomtherapy is currently the standard practice for treating neuromuscular dysfunction in snake envenoming. We reviewed the clinical and experimental evidence-base for the efficacy and effectiveness of antivenom in snakebite neurotoxicity.
Anjana Silva   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy